Nephroplus Q3 FY26 Investor Call Audio Recording Available
Nephrocare Health Services Limited released the audio recording of its investor conference call held on February 11, 2026. The call focused on the Q3 and nine months ended December 31, 2025, financial results. The recording is available on the company website.
This is a standard disclosure providing access to previously discussed financial information via an audio recording. It does not introduce new material information or significantly alter the understanding of the company's performance or future prospects.
The announcement is a routine update providing a link to an audio recording of a conference call discussing financial results. It does not contain new financial information or forward-looking statements that would indicate a positive or negative sentiment.
Nephrocare Health Services Limited (NEPHROPLUS) has made available the audio recording of its Investors' Conference Call. The call was held on February 11, 2026, to discuss the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.
The link to the audio recording is provided as https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/investors-analysts-meet/2025-26/Investor_Call_Audio_Q3FY26.mp3. This recording has also been uploaded to the company's official website at www.nephroplus.com.
This announcement follows up on a previous letter dated January 30, 2026, and is made in compliance with Regulation 30, 46(2), and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.